Evidence map›Paper›PMID 32781647›Full record

ArticleBiomedicines2020

Vivostat Platelet-Rich Fibrin

Andreas Bayer, Gesa Höntsch, Mark Kaschwich, Annika Dell, Markus Siggelkow, Rouven Berndt, Rene Rusch, Jürgen Harder, Regine Gläser, Jochen Cremer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Andreas BayerInstitute of Anatomy, Kiel University, Olshausenstr. 40, 24098 Kiel, Germany.
Gesa HöntschDepartment of Heart and Vascular Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Haus C, 24105 Kiel, Germany.
Mark KaschwichDepartment of Surgery, University Hospital of Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
Annika DellDepartment of Surgery, University Hospital of Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
Markus SiggelkowDepartment of Vascular and Thoracic Surgery, Imland Clinic Rendsburg, Lilienstraße 20-28, 24768 Rendsburg, Germany.
Rouven BerndtDepartment of Heart and Vascular Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Haus C, 24105 Kiel, Germany.ORCID 0000-0002-4053-6235
Rene RuschDepartment of Heart and Vascular Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Haus C, 24105 Kiel, Germany.
Jürgen HarderDepartment of Dermatology, Kiel University, Rosalind-Franklin-Str. 9, 24105 Kiel, Germany.
Regine GläserDepartment of Dermatology, Kiel University, Rosalind-Franklin-Str. 9, 24105 Kiel, Germany.
Jochen CremerDepartment of Heart and Vascular Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Haus C, 24105 Kiel, Germany.
University Hospital Schleswig-Holstein · DEChristian-Albrechts-Universität zu Kiel · DEInstitut für Berufliche Aus- und Fortbildung · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vivostat Platelet-Rich Fibrin

Indexed as

chronic woundcomplicated woundindividualized wound therapyVivostat platelet-rich fibrin (PRF)

Identifiers

PMID32781647
PMCPMC7459803
OpenAlexW3047077003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.